Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study

Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study

Source: 
Pharmaceutical Business Review
snippet: 

Claritas Pharmaceuticals and CMAX Clinical Research have signed an agreement to conduct a Phase 1 clinical study of R-107.